Lateral flow assays (LFAs) have been on the market as a tool for performing fast diagnostic tests for several decades. Clinical professionals use LFAs routinely, and the public have gained familiarity outside the healthcare environment through over-the-counter devices, such as pregnancy tests.
In this webinar we will explore the future of LFAs, discussing the various applications where these immunodiagnostic tests are starting to make an impact and how LFAs can help progress molecular diagnostics in a variety of fields.
Attend this webinar to learn:
The history of lateral flow assay tests, in brief
The new applications that are enabling molecular diagnostics to make a big impact
Evolution of LFAs, from an immunodiagnostic test to a full technological breakthrough
How implementing best practice thinking can be applied to molecular diagnostics now
Dr. Klaus Hochleitner Global Lead Technical Product Specialist GE Healthcare Life Sciences
Brendan O'Farrell President DCN Diagnostics
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK